Physician profile

Rajesh B Vrushab

Cardiovascular Disease · Bedford, TX

NPI 1366405268

$21,446.39

in general payments reported to CMS, 2019-2025

49 companies · $4,443 in 2025

The $4,443 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,283.11
Travel and Lodging$2,328.75
Education$10.10

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $8,282.60 2019-2025 Gallant, Aveir, Assurity
Medtronic, INC. $2,979.23 2022-2025 Symplicity G3, Azure Xt Dr Mri Surescan
Novartis Pharmaceuticals Corporation $1,239.93 2019-2025
Astrazeneca Pharmaceuticals LP $869.35 2019-2025 Farxiga
Biosense Webster, INC. $749.88 2023-2025 Carto 3, Nuvision Ice Catheter, Na
Amgen INC. $636.42 2019-2025 Repatha
Janssen Pharmaceuticals, INC $603.11 2019-2024 Xarelto
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $601.40 2019-2025 Lifevest
Pfizer INC. $565.13 2021-2025
Merck Sharp & Dohme LLC $536.41 2021-2025 Verquvo, Capvaxive
Boehringer Ingelheim Pharmaceuticals, INC. $516.67 2019-2025 Jardiance
Amarin Pharma, INC. $435.58 2019-2022
Boston Scientific Corporation $410.09 2023-2025 Farapulse, Bodyguardian, Watchman Flx
Esperion Therapeutics, INC. $408.63 2020-2024 Nexletol
Alnylam Pharmaceuticals INC. $358.36 2021-2025 Onpattro, Amvuttra
Show all 49 companies
CompanyGeneral paymentsYearsTop products
Sanofi-Aventis U.S. LLC $296.36 2019-2024
Astellas Pharma US INC $229.53 2019-2020
E.R. Squibb & Sons, L.L.C. $205.02 2019-2025 Camzyos, Eliquis
Philips North America LLC $189.86 2020-2025 (Ck7) Extended Holter, Extended Holter, Lm Undivided
Novo Nordisk INC $181.38 2021-2025 Wegovy, Ozempic
Lundbeck LLC $120.36 2019-2021
Bardy Diagnostics, INC. $95.00 2019-2020
Scpharmaceuticals INC. $87.00 2024-2025
Kiniksa Pharmaceuticals, LTD. $79.74 2021-2023 Arcalyst
Edwards Lifesciences Corporation $72.11 2019-2025 Sapien 3 Ultra Resilia
Inspire Medical Systems, INC. $67.96 2023-2025 Inspire
Atricure, INC. $52.15 2022
Actelion Pharmaceuticals US, INC. $46.94 2024-2025 Opsumit
Glaxosmithkline, LLC. $43.75 2025 Arexvy, Shingrix
Gilead Sciences, INC. $43.14 2019
G Medical Diagnostic Services, INC. $41.54 2022-2023 Cardiac Monitoring Suite
Baxter Healthcare $39.66 2024-2025 Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor
Vital Connect, INC $36.42 2025 Vitalpatch Rtm
Kestra Medical Technology Services, INC. $35.61 2025 Assure Wcd
Ionis Pharmaceuticals, INC. $29.95 2025 Tryngolza
Penumbra, INC. $24.69 2022
Terumo Medical Corporation $22.21 2021
Cardiovascular Systems INC. $22.13 2022
Kiniksa Pharmaceuticals International, Plc $21.87 2024 Arcalyst
Lexicon Pharmaceuticals, INC. $21.54 2023 Inpefa
Lantheus Medical Imaging, INC. $20.69 2025
Stryker Corporation $20.35 2020
Mannkind Corporation $19.89 2025
Arbor Pharmaceuticals, INC. $18.84 2021
Convatec INC. $18.77 2023
Regeneron Healthcare Solutions, INC. $13.53 2019
Cardiva Medical, INC. $12.11 2019
Angiodynamics, INC. $11.85 2022
Biotronik INC. $11.65 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Rajesh B Vrushab

$21,446.39

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $4,443 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/61948/rajesh-b-vrushab

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.